Noelle Frey

Noelle Frey, an expert in CAR-T therapy and leukemia treatment, discusses the future of CAR-T therapy in ALL. Topics include the impact of tisagenlecleucel approval, promise of allogeneic products, improving response durability, reducing relapses, targeting multiple antigens, and off-the-shelf therapy for ALL.

Acute leukemia experts Noelle Frey, Bianca Santomasso, and Wendy Stock discuss topics such as treatment improvements, CAR T-cell therapy outcomes and toxicities, and the importance of problem definition in acute leukemia. They also address the use of new agents like inotuzumab and the grading of neurologic toxicity. This podcast provides valuable insights into the advancements and challenges in managing acute leukemia.